U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a new federal initiative to build a comprehensive autism data platform using Medicare and Medicaid records. Designed to study the causes of autism spectrum disorder (ASD), the platform will integrate claims data, electronic health records, and data from wearable health devices, according to the Department of Health and Human Services (HHS).
The National Institutes of Health (NIH) and the Centers for Medicare and Medicaid Services (CMS) will collaborate on the effort, which is part of a broader $50 million research initiative to investigate potential environmental and medical causes of autism. Kennedy stated the project aims to provide "honest answers families have waited far too long to hear," despite his controversial history promoting a debunked link between vaccines and autism.
HHS said the platform will help researchers analyze autism diagnoses, treatment outcomes, healthcare access disparities, and the financial impact on families. However, experts like Dr. Helen Tager-Flusberg of Boston University argue the focus does not directly address autism’s root causes. She also noted that an existing NIH autism database recently went offline without explanation, raising concerns about transparency.
The project has sparked privacy questions, as HHS has not confirmed whether the database will be anonymous or voluntary. Autism researcher Eric Rubenstein noted that Medicaid and Medicare data offer insights into health disparities but lack environmental exposure data, which Kennedy claims he will explore.
Autism rates have surged in recent years, with the CDC reporting 1 in 31 U.S. 8-year-olds diagnosed in 2022. While Kennedy aims to identify autism’s causes by September, scientists emphasize that autism likely stems from a complex mix of genetic and environmental factors. Critics warn against oversimplifying this ongoing scientific challenge.


Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Trump Signs “America First Arms Transfer Strategy” to Prioritize U.S. Weapons Sales
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Federal Judge Blocks Trump Administration Move to End TPS for Haitian Immigrants
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
U.S. Eases Venezuela Oil Sanctions to Boost American Investment After Maduro Ouster
Pentagon and Anthropic Clash Over AI Safeguards in National Security Use
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
FDA Approves Mitapivat for Anemia in Thalassemia Patients
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Paul Atkins Emphasizes Global Regulatory Cooperation at Fintech Conference
Trump Proposes Two-Year Shutdown of Kennedy Center Amid Ongoing Turmoil
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025 



